Cancer Research Meeting Calendar  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, G.-L.
Right arrow Articles by Huang, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, G.-L.
Right arrow Articles by Huang, S.
[Cancer Research 61, 1796-1798, March 1, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

Adenovirus Expressing RIZ1 in Tumor Suppressor Gene Therapy of Microsatellite-unstable Colorectal Cancers1

Guang-Liang Jiang and Shi Huang2

The Burnham Institute, La Jolla, California 92037

Viral vector-mediated delivery of tumor suppressor genes represents a promising strategy of cancer therapy. Several best-studied tumor suppressor genes, such as p53 and retinoblastoma (Rb), have been evaluated for gene therapy of tumors that carry mutations in these genes. However, these genes may not be applicable to microsatellite instability positive [MSI(+)] tumors because they are rarely mutated in these tumors. The Rb-interacting zinc finger gene RIZ1 is commonly mutated in MSI(+) colorectal, gastric, and endometrial cancers and has demonstrated a capacity to induce cell cycle arrest and apoptosis. Here, we found that RIZ1 expression through adenovirus vectors suppressed growth of MSI(+) HCT116 colorectal xenograft tumors that carry RIZ1 mutations. Malignant cells in the established tumors were efficiently transduced by RIZ1 adenoviruses and underwent apoptosis in response to RIZ1 expression. In comparison, a recombinant p53 adenovirus did not induce apoptosis and tumor suppression. These results suggest that RIZ1 may be useful in gene therapy of MSI(+) colorectal cancers.




This article has been cited by other articles:


Home page
Cancer Res.Home page
K.-C. Kim, L. Geng, and S. Huang
Inactivation of a Histone Methyltransferase by Mutations in Human Cancers
Cancer Res., November 15, 2003; 63(22): 7619 - 7623.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
D. H Palmer, M.-J. Chen, and D. J Kerr
Gene therapy for colorectal cancer
Br. Med. Bull., December 1, 2002; 64(1): 201 - 225.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Du, T. Carling, W. Fang, Z. Piao, J.-C. Sheu, and S. Huang
Hypermethylation in Human Cancers of the RIZ1 Tumor Suppressor Gene, a Member of a Histone/Protein Methyltransferase Superfamily
Cancer Res., November 1, 2001; 61(22): 8094 - 8099.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
G. Steele-Perkins, W. Fang, X.-H. Yang, M. Van Gele, T. Carling, J. Gu, I. M. Buyse, J. A. Fletcher, J. Liu, R. Bronson, et al.
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily
Genes & Dev., September 1, 2001; 15(17): 2250 - 2262.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.